Medicare Enrolled
Dr. Donald Miller, M.D.
Rheumatology · Bryn Mawr, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Miller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miller?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Miller
Dr. Donald Miller is a rheumatology specialist in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Miller performed 257,745 Medicare services across 1,673 unique beneficiaries.
Between the years covered by Open Payments, Dr. Miller received a total of $15,937 from 63 pharmaceutical and/or device companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Miller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in PA
$15,937 industry payments
Medicare Practice Summary
Medicare Utilization ↗257,745
Medicare services
Top 2% in PA for rheumatology
1,673
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~12,887 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 121,200 | $5 | $15 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
94,400 | $4 | $10 |
| Denosumab injection (Prolia/Xgeva) | 13,740 | $18 | $40 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
12,400 | $34 | $65 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
9,120 | $26 | $115 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
2,700 | $64 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
929 | $12 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
865 | $97 | $218 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
644 | $110 | $322 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
437 | $69 | $143 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
340 | $6 | $113 |
| Injection, methylprednisolone acetate, 40 mg | 207 | $6 | $20 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
194 | $24 | $72 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
182 | $1 | $11 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
72 | $58 | $149 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
61 | $48 | $170 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
61 | $126 | $255 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
44 | $13 | $55 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
38 | $76 | $110 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
38 | $32 | $40 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
29 | $4 | $25 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $47 | $89 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
16 | $44 | $101 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.6% high complexity
90.8% medium
0.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,937
Total received (2018-2024)
Avg $2,277/year across 7 years
Top 22% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
748
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,136 (95.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$801 (5.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,555
2023
$3,014
2022
$2,546
2021
$1,561
2020
$1,302
2019
$2,743
2018
$2,215
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$371
AstraZeneca Pharmaceuticals LP
$328
Amgen Inc.
$227
Novartis Pharmaceuticals Corporation
$191
Alexion Pharmaceuticals, Inc.
$183
ANI Pharmaceuticals, Inc.
$169
Fresenius Kabi USA, LLC
$145
Lilly USA, LLC
$142
Genentech USA, Inc.
$117
GENZYME CORPORATION
$73
PFIZER INC.
$72
Organon Llc
$60
Sandoz Inc.
$60
UCB, Inc.
$57
Radius Health, Inc.
$55
Janssen Biotech, Inc.
$48
SCILEX PHARMACEUTICALS INC.
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
E.R. Squibb & Sons, L.L.C.
$32
GlaxoSmithKline, LLC.
$23
Aurinia Pharma U.S., Inc.
$22
Kyowa Kirin, Inc.
$20
Mallinckrodt Hospital Products Inc.
$18
Fidia Pharma USA Inc.
$18
Kiniksa Pharmaceuticals International, plc
$17
Alvogen Inc
$17
DePuy Synthes Sales Inc.
$15
Top 3 companies account for 36.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,287
AstraZeneca Pharmaceuticals LP
$1,548
ABBVIE INC.
$943
UCB, Inc.
$918
Novartis Pharmaceuticals Corporation
$889
PFIZER INC.
$833
Janssen Biotech, Inc.
$758
Boehringer Ingelheim Pharmaceuticals, Inc.
$476
Genentech USA, Inc.
$406
Alexion Pharmaceuticals, Inc.
$370
Lilly USA, LLC
$338
ANI Pharmaceuticals, Inc.
$328
AbbVie, Inc.
$326
E.R. Squibb & Sons, L.L.C.
$308
Radius Health, Inc.
$295
Flexion Therapeutics, Inc.
$288
Bayer HealthCare Pharmaceuticals Inc.
$283
GlaxoSmithKline, LLC.
$274
GENZYME CORPORATION
$254
Amarin Pharma Inc.
$250
Mallinckrodt Hospital Products Inc.
$244
Celgene Corporation
$238
Merck Sharp & Dohme Corporation
$211
AbbVie Inc.
$190
Bioventus LLC
$172
Fresenius Kabi USA, LLC
$170
Takeda Pharmaceuticals U.S.A., Inc.
$137
Exeltis, USA Inc.
$134
Sandoz Inc.
$128
DePuy Synthes Sales Inc.
$127
Insmed, Inc.
$125
Paratek Pharmaceuticals, Inc.
$123
Otsuka America Pharmaceutical, Inc.
$120
Actelion Pharmaceuticals US, Inc.
$111
Horizon Therapeutics plc
$111
Shire North American Group Inc
$102
Aurinia Pharma U.S., Inc.
$102
Mallinckrodt Enterprises LLC
$89
Cumberland Pharmaceuticals, Inc.
$83
Hikma Pharmaceuticals USA
$63
Organon Llc
$60
Sobi, Inc
$60
IBSA Pharma Inc.
$56
Mallinckrodt LLC
$51
Organon LLC
$48
Antares Pharma, Inc.
$46
Ultragenyx Pharmaceutical Inc.
$46
SCILEX PHARMACEUTICALS INC.
$43
MEDEXUS PHARMA, INC.
$42
SOBI, INC
$38
Kiniksa Pharmaceuticals, Ltd.
$36
Fidia Pharma USA Inc.
$34
Ironwood Pharmaceuticals, Inc
$30
MEDAC PHARMA, INC.
$28
Ferring Pharmaceuticals Inc.
$28
Horizon Pharma plc
$24
Kyowa Kirin, Inc.
$20
SANOFI-AVENTIS U.S. LLC
$19
Kiniksa Pharmaceuticals International, plc
$17
Alvogen Inc
$17
Celltrion USA Inc.
$14
West-Ward Pharmaceuticals
$14
Mission Pharmacal Company
$12
Top 3 companies account for 30.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Aimovig · Aquoral · Arcalyst · Arikayce · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · Crysvita · Cryvista · DIFICID · DUZALLO · Durolane · EUFLEXXA · EVENITY · Enbrel · FASENRA · FORTEO · GATTEX · HADLIMA · HUMIRA · HYMOVIS · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · JARDIANCE · JYNARQUE · KEVZARA · KINERET · KRYSTEXXA · Kerendia · Kineret · LUMIZYME · LUPKYNIS · LYRICA · Licart · MONOVISC · Mitigare · NUCALA · NUZYRA · OFEV · OPSUMIT · ORENCIA · ORTHOVISC · Otezla · Otrexup · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REDITREX · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SOVUNA · SPEVIGO · STELARA · STRENSIQ · SYNVISC-ONE · Strensiq · TAGRISSO · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tirosint · Tyenne · Tymlos · UBRELVY · UPTRAVI · Uloric · Vascepa · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
178
Per 100K population
30.9
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Miller is a mixed practice specialist, with above-average Medicare volume (top 2% in PA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Miller experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Miller performed 121,200 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miller receive payments from pharmaceutical companies?
Yes. Dr. Miller received a total of $15,937 from 63 companies across 748 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miller's costs compare to other rheumatologists in Bryn Mawr?
Dr. Miller's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Bryn Mawr
Browse rheumatologists in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in PA
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in PA
Which PA rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology